Registry to Evaluate INOmax in Newborn Babies With Pulmonary Hypertension

Stopped early

Conditions studied: Pulmonary Hypertension of Newborn

In brief

Pulmonary hypertension is high blood pressure in the arteries to the lungs. It is a serious condition. It causes the blood vessels that carry blood from the heart to the lungs to become hard and narrow. When this happens, the heart has to work harder to pump the blood through. Some babies are born with pulmonary hypertension (PH). Doctors might use INOmax (a gas the baby breathes) to help newborn babies (neonates) with PH. This study will use information from the records of registered babies to see how effective and safe INOmax is for treating premature and other newborn babies for up to 11 days after they are born.

Key facts

Study ID
NCT03132428
Run by
Mallinckrodt
People needed
140
Starts
2017-07-27
Expected to finish
2020-02-11
Last updated by the study team
2020-06-18

Who can join

Age: 1 and older, up to 1. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.